Personalized immunotherapy to fight deadly brain tumors
April 13, 2023
The University of Cincinnati is enrolling patients in an Imvax study that will test the effectiveness of a personalized vaccine approach to fight deadly brain tumors.
April 13, 2023
The University of Cincinnati is enrolling patients in an Imvax study that will test the effectiveness of a personalized vaccine approach to fight deadly brain tumors.
April 21, 2023
Local 12 and WCPO highlighted the Imvax trial being hosted at the University of Cincinnati that is testing the effectiveness of a personalized vaccine approach to fight deadly brain tumors.
November 23, 2018
University of Cincinnati graduate student trustee working on her PhD in neuroscience and epilepsy research, Christin Godale says while growing up she struggled to manage the seizures that would strike without warning.
November 13, 2023
A new clinical trial underway at the UC Gardner Neuroscience Institute is applying a personalized approach to pain management that doctors hope can improve post-surgical pain, reduce opioid dependence and reduce length of hospital stays.
October 27, 2023
A new large-scale study led by researchers at the University of Cincinnati and Northwell Health found the drug metformin can help prevent or reduce weight gain in youth taking medication to treat bipolar disorder.
May 1, 2024
Researchers at the University of Cincinnati and Dell Medical School at the University of Texas at Austin are leading a study using state-of-the-art neuroimaging techniques and artificial intelligence to identify changes in the brains among children of adults living with bipolar disorder.
April 1, 2022
Medscape featured the University of Cincinnati's Dr. Donald Gilbert in an article about a new drug that has been shown to be effective in reducing tics in Tourette syndrome patients while causing less side effects.